Literature DB >> 24752800

NK cells gain higher IFN-γ competence during terminal differentiation.

Merlin Luetke-Eversloh1, Basak B Cicek, Francesco Siracusa, Jenny T Thom, Alf Hamann, Stefan Frischbutter, Ria Baumgrass, Hyun-Dong Chang, Andreas Thiel, Jun Dong, Chiara Romagnani.   

Abstract

NK cells are the main cells of the innate immune system that produce IFN-γ, and they express this cytokine at early stages of maturation in response to cytokine stimulation. Conversely, acquisition of IFN-γ-competence in CD4(+) T helper cells requires a differentiation process from naïve toward type 1 (Th1) cells, which is associated with epigenetic remodeling at the IFNG locus. In the present study, we show that the ability of NK cells to produce IFN-γ in response to activating receptor (actR) engagement is gradually acquired during terminal differentiation and is accompanied by progressively higher NF-κB activation in response to actR triggering. Moreover, during the differentiation process NK cells gradually display increasing expression of IFNG and TBX21 (encoding T-bet) transcripts and demethylation at the IFNG promoter. This study provides new insights in the molecular mechanisms underlying NK-cell ability to express IFN-γ upon actR engagement. Thus, we propose that in order to efficiently produce IFN-γ in response to infected or transformed cells, NK cells gain Th1-like features, such as higher IFN-γ competence and epigenetic remodeling of the IFNG promoter, during their terminal differentiation.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cell differentiation; Chromatin remodeling; IFN-γ; NK cells

Mesh:

Substances:

Year:  2014        PMID: 24752800     DOI: 10.1002/eji.201344072

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

Review 1.  Harnessing adaptive natural killer cells in cancer immunotherapy.

Authors:  Lisa L Liu; Aline Pfefferle; Vincent Oei Yi Sheng; Andreas T Björklund; Vivien Béziat; Jodie P Goodridge; Karl-Johan Malmberg
Journal:  Mol Oncol       Date:  2015-10-20       Impact factor: 6.603

2.  The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector.

Authors:  Wenjuan Dong; Xiaojin Wu; Shoubao Ma; Yufeng Wang; Ansel P Nalin; Zheng Zhu; Jianying Zhang; Don M Benson; Kai He; Michael A Caligiuri; Jianhua Yu
Journal:  Cancer Discov       Date:  2019-07-24       Impact factor: 39.397

3.  NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial Immunity.

Authors:  Natalija Simonović; Agnieszka Witalisz-Siepracka; Katrin Meissl; Caroline Lassnig; Ursula Reichart; Thomas Kolbe; Matthias Farlik; Christoph Bock; Veronika Sexl; Mathias Müller; Birgit Strobl
Journal:  J Immunol       Date:  2019-02-04       Impact factor: 5.422

4.  The DNA methylation profile of activated human natural killer cells.

Authors:  John K Wiencke; Rondi Butler; George Hsuang; Melissa Eliot; Stephanie Kim; Manuel A Sepulveda; Derick Siegel; E Andres Houseman; Karl T Kelsey
Journal:  Epigenetics       Date:  2016-03-11       Impact factor: 4.528

Review 5.  Origins of natural killer cell memory: special creation or adaptive evolution.

Authors:  Kayla A Holder; Emilie M Comeau; Michael D Grant
Journal:  Immunology       Date:  2018-02-15       Impact factor: 7.397

6.  Eomesodermin and T-bet mark developmentally distinct human natural killer cells.

Authors:  Amélie Collins; Nyanza Rothman; Kang Liu; Steven L Reiner
Journal:  JCI Insight       Date:  2017-03-09

7.  Genome-wide analyses and functional profiling of human NK cell lines.

Authors:  Justin T Gunesch; Laura S Angelo; Sanjana Mahapatra; Raquel P Deering; Johanna E Kowalko; Patrick Sleiman; John W Tobias; Linda Monaco-Shawver; Jordan S Orange; Emily M Mace
Journal:  Mol Immunol       Date:  2018-07-24       Impact factor: 4.407

Review 8.  Metabolic Regulation of Natural Killer Cell IFN-γ Production.

Authors:  Annelise Y Mah; Megan A Cooper
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

Review 9.  Targeting the epigenetic regulation of antitumour immunity.

Authors:  Simon J Hogg; Paul A Beavis; Mark A Dawson; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2020-09-14       Impact factor: 84.694

Review 10.  Spatial and temporal coordination of antiviral responses by group 1 ILCs.

Authors:  Nicholas M Adams; Joseph C Sun
Journal:  Immunol Rev       Date:  2018-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.